News & Updates

Show Multimedia Only

Lepodisiran lowers lipoprotein(a) concentrations in early trial

17 Nov 2023

Treatment with lepodisiran yields dose-dependent and durable reductions in serum lipoprotein(a) levels while being well tolerated, according to the results of a phase I trial.

Lepodisiran lowers lipoprotein(a) concentrations in early trial

17 Nov 2023

Real-world data back sodium zirconium cyclosilicate for hyperkalemia in HD patients

15 Nov 2023 by

The novel potassium binder, sodium zirconium cyclosilicate, has proven to be safe and effective for lowering potassium levels in the blood of Asian patients undergoing maintenance haemodialysis (HD) treatments, as shown in a study from Singapore.

Real-world data back sodium zirconium cyclosilicate for hyperkalemia in HD patients

15 Nov 2023

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

New drug applications approved by US FDA as of 01-15 November 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 November 2023)

15 Nov 2023

Is salt in foods a risk factor for type 2 diabetes?

14 Nov 2023 by

Frequently adding salt to foods increases not only the risk of hypertension but the risk of type 2 diabetes (T2D) as well, as reported in a large study.

Is salt in foods a risk factor for type 2 diabetes?

14 Nov 2023

Medical nutrition therapy a boon for adults with prediabetes

12 Nov 2023

Medical nutrition therapy (MNT) provided by a dietitian results in improved glycaemic outcomes, anthropometrics, blood pressure, and most lipid levels in prediabetic adults, according to a systematic review and meta-analysis.

Medical nutrition therapy a boon for adults with prediabetes

12 Nov 2023

Sugar, except from fruits and veggies, ups risk of CHD

11 Nov 2023

Consumption of total sugar, total glucose equivalents (TGE), added sugar, and fructose from added sugar and juice appears to increase the risk of coronary heart disease (CHD), reveals a study. However, intake of total fructose equivalents (TFE) and fructose from fruits and vegetables does not.

Sugar, except from fruits and veggies, ups risk of CHD

11 Nov 2023

Binge eating, less self-monitoring lead to regain in successful weight losers

08 Nov 2023

Overeating in response to internal and external food cues as well as declines in self-monitoring and body image contribute to weight regain in successful weight losers in a weight-management program, reports a recent study.

Binge eating, less self-monitoring lead to regain in successful weight losers

08 Nov 2023

Original New Drug Application Approvals by US FDA (16-31 October 2023)

08 Nov 2023

New drug applications approved by US FDA as of 16-31 October 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2023)

08 Nov 2023

Diabetes, obesity tied to upstaging in renal cell carcinoma

07 Nov 2023

Diabetes and higher body mass index (BMI) contribute to pathological upstaging in renal cell carcinoma, according to a study. Preoperative tumour size, increased age, and male sex are also significantly associated with upstaging.

Diabetes, obesity tied to upstaging in renal cell carcinoma

07 Nov 2023

Synbiotic supplementation of high-fibre diet promising for weight loss

07 Nov 2023 by

An open-label, randomized, parallel-design clinical trial demonstrates weight loss as well as decreases in fasting glucose, insulin and insulin resistance in overweight and obese Hong Kong Chinese individuals after high-fibre dietary intervention supplemented with synbiotics.

Synbiotic supplementation of high-fibre diet promising for weight loss

07 Nov 2023

News & Updates

Filter by Specialty:

Specialty:

Lepodisiran lowers lipoprotein(a) concentrations in early trial

Lepodisiran lowers lipoprotein(a) concentrations in early trial

Real-world data back sodium zirconium cyclosilicate for hyperkalemia in HD patients

Real-world data back sodium zirconium cyclosilicate for hyperkalemia in HD patients

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Original New Drug Application Approvals by US FDA (01-15 November 2023)

Is salt in foods a risk factor for type 2 diabetes?

Is salt in foods a risk factor for type 2 diabetes?

Medical nutrition therapy a boon for adults with prediabetes

Medical nutrition therapy a boon for adults with prediabetes

Sugar, except from fruits and veggies, ups risk of CHD

Sugar, except from fruits and veggies, ups risk of CHD

Binge eating, less self-monitoring lead to regain in successful weight losers

Binge eating, less self-monitoring lead to regain in successful weight losers

Original New Drug Application Approvals by US FDA (16-31 October 2023)

Original New Drug Application Approvals by US FDA (16-31 October 2023)

Diabetes, obesity tied to upstaging in renal cell carcinoma

Diabetes, obesity tied to upstaging in renal cell carcinoma

Synbiotic supplementation of high-fibre diet promising for weight loss

Synbiotic supplementation of high-fibre diet promising for weight loss